Treatments for gastrointestinal disorders
DCFirst Claim
1. A peptide or a pharmaceutically acceptable salt thereof, wherein the peptide comprises the amino acid structure of
2 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention features peptides, compositions, and related methods for treating gastrointestinal disorders and conditions, including but not limited to, irritable bowel syndrome (IBS), gastrointestinal motility disorders, functional gastrointestinal disorders, gastroesophageal reflux disease (GERD), duodenogastric reflux, Crohn'"'"'s disease, ulcerative colitis, inflammatory bowel disease, functional heartburn, dyspepsia, visceral pain, gastroparesis, chronic intestinal pseudo-obstruction (or colonic pseudo-obstruction), disorders and conditions associated with constipation, and other conditions and disorders are described herein, using peptides and other agents that activate the guanylate cyclase C (GC-C) receptor.
55 Citations
20 Claims
- 1. A peptide or a pharmaceutically acceptable salt thereof, wherein the peptide comprises the amino acid structure of
Specification